Michael Rogers Has Adverse Analytical Finding For Clenbuterol

Michael Rogers_2012_Olympics

Today, Michael Rogers has been advised by the UCI that he returned an adverse analytical finding for clenbuterol in an A-sample taken in connection with Japan Cup on the 20th October 2013.

Michael Rogers immediately informed Saxo-Tinkoff’s management about the notification from the UCI.

The Australian explained to the team management that he never ingested the substance knowingly nor deliberately and fears that the adverse analytical finding origins from a contaminated food source.

Michael Rogers participated in Tour of Beijing the week before the Japan Cup and travelled directly from China to Japan.

Michael Rogers now has the opportunity to request an analysis of his B-sample. According to the team’s Anti Doping policy, Michael Rogers is provisionally suspended with immediate effect.

Until further facts are available to the team, Saxo-Tinkoff has no further comments on the matter.